HRSA Put Two Teaching Health Center Competitions on the Calendar This Fall, and Every Dollar Figure in Both Is a Multiple of 160,000

Most federal award ranges are soft. An agency estimates a floor and a ceiling, reviewers score narratives, program officers negotiate, and the final numbers land somewhere in the neighborhood.

The Teaching Health Center Graduate Medical Education program does not work that way, and if you treat its two open competitions like ordinary discretionary grants you will misread both of them.

Look at the numbers HRSA published for this fall:

HRSA-27-017 — posted July 8, 2026, applications due September 29, 2026. Approximately $20,960,000, about 12 awards, range $320,000 to $2,880,000. Period of performance begins July 1, 2027.

HRSA-27-084 — posted July 27, 2026, applications due November 16, 2026. $16,000,000, 12 awards, range $160,000 to $960,000. Estimated award date June 1, 2027; project start July 1, 2027.

Now divide everything by 160,000.

The floor of HRSA-27-084 is exactly 1. Its ceiling is exactly 6. The floor of HRSA-27-017 is 2; its ceiling is 18. The total pot of HRSA-27-084 is exactly 100. The total pot of HRSA-27-017 is exactly 131.

Those are not dollars. They are resident full-time equivalents, priced at the anticipated interim payment rate of $160,000 per resident FTE.

The per-resident amount is the entire program

THCGME is a payment program dressed as a grant program. HRSA funds the training of residents in accredited primary care residency programs operating inside community-based ambulatory patient care centers — federally qualified health centers, community mental health centers, rural health clinics, tribal and Indian Health Service facilities — in family medicine, internal medicine, pediatrics, internal medicine-pediatrics, obstetrics and gynecology, psychiatry, geriatrics, general dentistry and pediatric dentistry.

The award is the per-resident amount multiplied by your filled, eligible FTE count. That is nearly the whole calculation.

This has three consequences that most first-time applicants discover too late.

Your budget narrative is a census, not a projection. The reviewable question is not "what will this cost" but "how many eligible resident FTEs will you actually have, and can you document them." An application that claims positions it cannot fill is not optimistic; it is proposing an award HRSA will have to claw back down at continuation.

The ceiling tells you the applicant profile. HRSA-27-084 tops out at six FTEs. That is a small program — a single small residency, or a new cohort at a health center that has never done GME before. HRSA-27-017 tops out at eighteen, and its floor of two FTEs excludes nobody meaningful. Two competitions, two different sizes of institution. If your program trains twenty-two residents, neither ceiling fits your full complement, and you need to know that before you build a budget around it.

Underfilling is the real risk, not overspending. Unlike a research grant where slow spending is an administrative annoyance, an unfilled FTE in a headcount-priced program is money that simply does not arrive, against fixed faculty and clinic costs you have already committed.

Run the ratio on your own program before you write a word: divide your realistic filled-FTE count by the ceiling. If the answer is above one, you are applying to the wrong instrument for part of your complement.

The 2029 horizon changes what a three-year application means

For most of its existence, THCGME has been the most precariously funded program in federal health workforce policy. It has lurched from short-term extension to short-term extension, sometimes with weeks of runway, forcing residency programs to make four-year training commitments against funding authority that expired in months. Program directors have described recruiting residents into a program they could not promise would exist in the resident's second year. The academic literature on this is blunt; a 2023 Journal of Graduate Medical Education piece framed permanent funding as an outright imperative rather than a policy preference.

That changed. The Consolidated Appropriations Act, 2026 — H.R. 7148, signed February 3, 2026 — funds THCGME through September 30, 2029.

Read the fall NOFOs against that date and the structure snaps into focus. Both competitions start performance on July 1, 2027. A standard three-year THCGME period of performance from that start runs to June 30, 2030 — just past the appropriation horizon, but with the first two years and change fully covered rather than year-to-year contingent. The prior continuation cycle, HRSA-26-011, ran July 1, 2026 through June 30, 2029 on the same logic.

For an applicant, this is the difference between a defensible recruitment pitch and a hopeful one. You can now tell an incoming resident that the funding authority behind their position is appropriated through the year they graduate. That is a recruiting argument, and given that THCGME programs compete for candidates against sponsoring institutions with Medicare GME money that has never once lapsed, it is not a small one.

It is also a reason to be precise in the narrative. The program's political case rests on outcomes: THCGME is one of the very few federal mechanisms that has actually increased the number of physician trainees in the past quarter century, and in academic year 2024-25 it supported more than 1,254 residents across 88 community-based residency programs, overwhelmingly in medically underserved areas and serving a patient population heavily covered by Medicaid. Applications that document retention — how many of your graduates still practice in underserved settings, and where — are arguing the case the program itself has to keep winning.

The eligibility trap, and what to verify this week

Here is where applicants lose the competition without ever being scored.

THCGME continuation and maintenance competitions have repeatedly been restricted to existing recipients. HRSA-26-011, the fall 2025 cycle, limited eligibility to current THCGME recipients funded under HRSA-22-105 and HRSA-22-139. HRSA-27-017 carries a comparable restriction to existing HRSA THCGME payment recipients. HRSA-27-084 is written more broadly, to community-based ambulatory patient care centers operating accredited primary care residency programs.

So the first thing to determine is not whether your program is strong. It is which of these two doors is open to you, and that depends on your funding history and your accreditation status — not on the quality of your training.

Three checks, in order, and all of them are faster than writing:

1. Confirm your prior-award lineage. Identify the exact opportunity number under which you currently receive THCGME payments. That string, not your program's name, is what the eligibility clause keys on.
2. Confirm accreditation status and timing. Eligibility runs through an accredited primary care residency program in a named specialty. If accreditation is pending, the date it is expected to land relative to the July 1, 2027 start is a threshold fact, not a detail.
3. Confirm SAM.gov and Grants.gov are active. HRSA's own NOFO front matter warns that SAM.gov registration can take several weeks and Grants.gov several days. With September 29 roughly five weeks out, a lapsed UEI is the one problem you cannot outrun.

Health centers weighing this against other HRSA instruments should note that the workforce and service-expansion streams operate on entirely different clocks and eligibility logic — the New Access Points competition earlier this month ran a 120-day operational clock that has nothing in common with a headcount-priced GME payment. And every recipient should be watching the compliance floor shift underneath all of it as the rewritten uniform grants regulation takes effect on October 1.

Two deadlines, seven weeks apart, priced in residents rather than dollars — the programs that do best are the ones that figured out which competition they belong in before they started drafting, and Granted is built for exactly that kind of upstream sorting.